Chad A Arledge
Overview
Explore the profile of Chad A Arledge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arledge C, Zhao A, Topaloglu U, Zhao D
medRxiv
. 2024 Sep;
PMID: 39281733
Dynamic contrast enhanced (DCE) MRI is a non-invasive imaging technique that has become a quantitative standard for assessing tumor microvascular permeability. Through the application of a pharmacokinetic (PK) model to...
2.
Wang L, Zhao A, Arledge C, Xing F, Chan M, Brekken R, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272945
Brain metastasis is the most common intracranial malignancy in adults. The prognosis is extremely poor, partly because most patients have more than one brain lesion, and the currently available therapies...
3.
Arledge C, Crowe W, Wang L, Bourland J, Topaloglu U, Habib A, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345039
The purpose of this study is to further validate the utility of our previously developed CNN in an alternative small animal model of BM through transfer learning. Unlike the glioma...
4.
Arledge C, Sankepalle D, Crowe W, Liu Y, Wang L, Zhao D
Front Biosci (Landmark Ed)
. 2022 Mar;
27(3):99.
PMID: 35345331
Background: Dynamic contrast-enhanced (DCE) MRI is widely used to assess vascular perfusion and permeability in cancer. In small animal applications, conventional modeling of pharmacokinetic (PK) parameters from DCE MRI images...